Prerpints.org logo
Preprint
Communication

Bovine Parainfluenza Virus 3 and Bovine Respiratory Syncytial Virus: Dominant Viral Players in Bovine Respiratory Disease Complex among Serbian Cattle

Altmetrics

Downloads

64

Views

33

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

22 April 2024

Posted:

22 April 2024

You are already at the latest version

Alerts
Abstract
Bovine Respiratory Disease Complex, a complex respiratory ailment in cattle, results from a combination of viral and bacterial factors, compounded by environmental stressors such as overcrowding, transportation, and adverse weather conditions. Its impact extends beyond mere health concerns, posing significant economic threats to the cattle industry. This study presents an extensive investigation into viral pathogens associated with BRDC in Serbian cattle, utilizing serum samples and nasal swabs. A cross-sectional study was conducted in 2024 across 65 randomly selected dairy farms in Serbia, excluding vaccinated farms. Farms were categorized by livestock count: small (≤50 animals), medium-sized (51-200 animals), and large (>200 animals). Serum samples from adult cattle older than 24 months were tested for antibodies against BVDV, BHV-1, BRSV, and BPIV3. Nasal swab samples from animals with respiratory signs were tested using PCR for viral genome detection. Results showed seropositivity for all four viruses across all farms, with BPIV3 exhibiting universal seropositivity. Medium-sized and large farms demonstrated higher seropositivity for BRSV and BHV-1 compared to small farms (p<.05). True seroprevalence estimates at the animal level were 84.29% for BRSV, 54.08% for BVDV, 90.61% for BHV-1, and 84.59% for BPIV3. PCR analysis of nasal swabs revealed positive detections for BRSV (20%), BHV-1 (1.7%), BVDV (8%), and BPIV3 (10.9%). Influenza D virus was not found in any of samples. This study provides critical insights into the prevalence and circulation of viral pathogens associated with BRDC in Serbian cattle, emphasizing the importance of surveillance and control measures to mitigate the impact of respiratory diseases in cattle populations.
Keywords: 
Subject: Biology and Life Sciences  -   Animal Science, Veterinary Science and Zoology

1. Introduction

Bovine respiratory disease complex (BRDC) refers to a multifactorial respiratory condition that affects cattle. It is caused by a combination of viral and bacterial pathogens, as well as environmental stressors such as overcrowding, transportation, and adverse weather conditions [1]. BRDC is a significant concern in the cattle industry as it can lead to substantial economic losses due to decreased productivity, treatment costs [2], and mortality that can reach 70% [3]. For example, even with yearly preventive vaccination, BRDC still imposes an estimated annual cost of approximately £80 million on the UK economy [4]. Bovine Respiratory Syncytial Virus (BRSV), Bovine Parainfluenca Virus 3 (BPIV3), Bovine Viral Diarrhoea Virus (BVDV). Bovine Herpesvirus 1 (BHV-1), Bovine Adenovirus (BadV), Bovine Corona virus (BoCV) are recognized as primary causes of respiratory ilness in cattle [5]. Influenza D Virus (IDV) was first identified in 2011 [6] and has since been confirmed in North America, Europe, and East Asia. Although it typically causes mild symptoms, recent metagenomic analyses have shown a positive association between IDV and BRDC [7]. Viral infections further exacerbate the conditions conducive to bacterial infections. The damage to the upper respiratory tract and impaired mucociliary clearance enhance bacterial adhesion to virus-infected cells, facilitating their growth and colony formation. This damage progresses to the tracheal mucosa epithelium, enabling bacteria to penetrate deeper into the respiratory tract. Viruses also hinder the function of macrophages and neutrophil leukocytes, crucial for host immune responses and phagocytosis [8]. BRDC affects animals with a range of symptoms lasting up to five days. They include fever, lethargy, anorexia, coughing, nasal and ocular discharges, and in severe cases, strenuous breathing while bacterial pathogens can trigger an acute phase response with systemic symptoms like fever, loss of appetite, and respiratory issues. Neonatal calf diarrhea, which can occur with or without fever, is also linked to BRD and may emerge after significant damage to the intestinal submucosa[9]. Though biosecurity and antibiotics are also pillars, control of BRDC relies on vaccines [10].However, despite advancements, current BRD vaccines show limited efficacy as indicated by the development of clinical disease even in vaccinated animals due to factors like improper administration, storage, and challenges in vaccinating young calves [4]. BRDC remains a persistent and widespread challenge globally, with significant prevalence observed across Europe. In Serbia, governmental initiatives targeting BRDC are notably absent, leaving vaccination against the disease optional. Moreover, the dearth of comprehensive data concerning the prevalence and ramifications of BRDC within the country further exacerbates the challenge of effectively managing this complex. Therefore, this study sought to address this critical gap by estimating the seroprevalence of viral infections deemed most significant within the BRDC complex.

2. Materials and Methods

This study was carried out using the serum samples from the State annual leukosis surveillance. Ethical approval or consent to participate was therefore not required.

2.1. Study Design and Sampling

Serum samples were obtained from annual enzootic bovine leukosis surveillance which include testing of all adult cattle older than 24 months. This cross-sectional study was conducted in 2024, encompassing 65 randomly selected dairy farms across Serbia where vaccination was not practised. These farms were classified based on their livestock count: small farms with up to 50 animals (n=50), medium-sized farms ranging from 51 to 200 animals (n=10), and large farms housing over 200 animals (n=5). The number of farms and individuals surveyed was determined based on a 2-stage sampling design. The herd-level sample size was calculated with an anticipated prevalence of 10%, a confidence level of 95%, and a precision of 0.05%, alongside data on the total number of cattle farms in Serbia obtained from the Statistical Office of the Republic of Serbia. The number of animals to be tested was determined to ensure 95% probability of detecting at least one positive animal if the herd is infected, considering the farm's animal count, an assumed prevalence of 20%, a confidence level of 95%, and a precision of 0.05%. Small farms with up to ten animals were entirely tested, resulting in 1000 samples, comprising 400 from small farms, 300 from medium-sized ones, and 300 from large farms. The nasal swabs were collected from animals exhibiting clinical signs of respiratory illness. In total, 175 nasal swabs were gathered.

2.2. Antibody Detection Tests

Serum samples were analyzed to identify antibodies against BVDV, BHV-1, BRSV, and BPIV3. Commercial ELISA kits were employed for assessing antibodies against BVDV (PrioCHECK™ Bovine BVDV Ab Plate Kit by Prionics, Switzerland), BHV-1 (ID Screen® IBR gB Competition by IDvet, France), and BRSV (INgezim BRSV Compac by Ingenasa, Spain). Sample preparation and testing procedures were carried out in accordance with the guidelines provided by the respective test manufacturers. The interpretation of test results was conducted individually, adhering to the specified cut-off values provided by the test producers. Specific antibodies against BPIV3 were assessed by hemagglutination inhibition (HI) using 0.5% chicken red blood cells and 4 hemagglutination units of SF4 strain of BPIV3 (ATCC-VR 281, American Bioresearch, USA). The antibody titer was determined as the reciprocal of the highest serum dilution that completely inhibited hemagglutination. The initial serum dilution was set at 1:4, with a seropositivity cutoff level established at 4.

2.3. PCR

Nasal swab samples were subjected to PCR testing to detect the presence of BVDV, BHV-1, BRSV, INF D, and BPIV3 genomes. Viral nucleic acids were extracted from the swabs using the IndiSpin Pathogen kit (Indical, Germany) according to the manufacturer's instructions, following immersion in 1ml of phosphate-buffered saline (PBS). Published primers for BVDV [11], BRSV [12], BHV-1 [13], 2004), IDV [14], and BPIV3 [15] were utilized for specific genome amplification. Real-time PCR was conducted using Luna® Universal qPCR Master Mix (NEB, USA) for BHV-1, while real-time RT-PCR was performed using Luna Universal Probe One-Step RT-qPCR Kit (NEB, USA) for BVDV, BRSV, and PI3. Gel-based RT-PCR was applied for IDV detection using OneStep RT-PCR (Qiagen, Germany).

2.4. Statistical Analysis

Descriptive statistical methods were used for the results analysis. The true seroprevalence was calculated using https://epitools.ausvet.com.au/trueprevalence for using imperfect test and 95% confidence level.

3. Results

None of the 65 farms tested seronegative for all four viruses. All farms tested seropositive for BPIV3. Additionally, all medium-sized and large farms were seropositive for BRSV and BHV-1. Conversely, significantly lower seropositivity was observed for BVDV (p<.05) and BHV-1 (p<.05) in small farms (Table 1) comparing to large and medium-size and large farms, respectively.
The true seroprevalence at animal level of BRSV was estimated at 84.29% (81.81%-86.5%, CI 95%). The true seroprevalence of BVDV is estimated to be 54.08%, (50.92%-57.21%, CI 95%). Regarding BHV-1, the true seroprevalence was 90.61% (88.54%-92.37%, CI 95%). Lastly, for BPIV3 true seroprevalence was 84.59% (82.14%-86.78%, CI 95%).
Of the 175 nasal swabs collected, 20% (n=35) tested positive for BRSV, 1.7% (n=3) for BHV-1, 8% (n=14) for BVDV, and 10.9% (n=19) for BPIV3. BRSV circulation was verified in 7 farms, comprising 2 large and 5 small ones. BHV-1 was confirmed at a single large farm. BVDV circulation was identified in 3 farms, with 2 being large and 1 medium-sized. BPIV3 was detected in 10 farms, evenly split between 5 large and 5 medium-sized ones. Influenca D virus was not detected in any of tested farms. Simultaneous circulation of BRSV and BPIV3 was detected on two large farms which were BVDV and BHV-1 seropositive. Simultaneous circulation of BVDV, BHHV-1 and BPIV3 was confirmed on one large farm.

4. Discussion

The study represents the first comprehensive investigation of viral pathogens associated with BRDC in Serbian cattle. Unlike European countries where eradication or control programs may be in place, Serbian farms grapple with BRDC without such support. Serbia's cattle structure is diverse, leading to varied outcomes, and the results are segmented based on farm size to reflect this diversity.
Although IDV has been reported to circulate throughout Europe since 2012, the virus was not detected in any of the tested samples in this study. Previous reports have suggested that seroprevalence could reach as high as 94.6% [16]. However, the positivity rate from nasal swab tests is usually less than 10% [16]. One limitation of this research was the lack of available serology tests that could accurately determine the prevalence of IDV infection in cattle in Serbia. Additionally, it's essential to consider the less intensive cattle import market in Serbia compared to other EU countries, which may impact the spread of the virus, thus its absence in Serbia It was shown that the virus shedding occurs after the import of young cattle, which contributes to a broader diffusion in countries of destination and facilitates viral spread through livestock trade [17]. Furthermore, although small farms in Serbia practice very low biosecurity measures, they tend to produce their own replacement cattle rather than purchasing them from larger farms, which can also limit the spread of IDV [18].
In contrast to IDV, BPIV3 emerged as the most prevalent respiratory viral pathogen in Serbia, irrespective of farm size in cattle. While the seroprevalence of BPIV3 varies globally, reaching 100% at the herd level in places like Iran [19], our study similarly found a herd seroprevalence of 100%. Furthermore, the BPIV3 genome was detected in 10.9% of nasal swabs in our study, aligning with previous research in Serbia, which reported a positivity rate of 6.7% using genome detection and virus isolation [20]. The average prevalence of BPIV3 in nasal swabs, as determined by PCR, was estimated at 7%, with age showing a significant influence but not farm type, consistent with our findings [21]. Considering the typical lack of control measures for BPIV3, even on large farms in Serbia, along with the virus's characteristics, such as efficient horizontal transmission, propensity for sub-clinical infections, and potential for reintroduction into herds [22], these results were anticipated.
Like BPIV3, BRSV also exhibited a trend toward 100% seroprevalence at the herd level in medium-sized and large farms. However, seroprevalence was notably lower in small farms, with 50% showing seronegativity. Among all viruses circulating in cattle, BRSV exhibits the highest pathogenicity, manifesting with clinical signs ranging from mild to moderate or even subclinical [23]. Despite the potential for farms to remain free from clinical symptoms due to the subclinical nature of the disease [24], this study highlighted that small farms could maintain seronegativity under extensive conditions. Nonetheless, efficient inter-herd transmission contributed to a high true seroprevalence of 84.29%. These findings echo other studies' findings, attributing the prevalence to year-round virus circulation [25] and repeated exposure leading to reinfections [26]. However, although 20% of positive nasal swabs from sick animals were higher than those of other authors [27], it should be noted that viral RNA can be detected up to 27 days [28] enabling its detection.
While BPIV3 and BRSV are commonly reported in cattle, several countries or regions have achieved freedom from BoHV-1 through the implementation of eradication programs [29]. However, in Irish beef cattle, the herd-level seroprevalence to BHV-1 was as high as 90%, with a mean within-herd prevalence of 40% [31]. Consistent with findings in other studies [30,31], significant disparities in seroprevalence among small and medium-sized and large farms were observed in this study. Reports from Estonia [31] indicated a substantial increase in herd prevalence with herd size, reaching 3.4% in the smallest category, consistent with previous studies from Serbia [33], while the mean within-herd prevalence was 37.8%, corresponding closely to our findings of 38.46%.
Moreover, seroprevalence tends to increase with age [32] due to latency and lifelong exposure to the virus. In this study, only animals aged 24 months and older were included in the seroprevalence estimation thus this association could not be confirmed. Contrary to serological findings, and owing to the nature of BHV-1, the virus itself was detected in only 1.7% of nasal swabs from sick animals. Similar observations were made in Slovenia, where the detection rate of BHV-1 was 0.75% [33]. However, considering age-related infection, the detection rate in young animals could be notably higher, as evidenced by findings from Poland, where BHV-1 genome was detected in 36.5% of nasal swabs from young beef cattle [34].
While several European countries have successfully eradicated Bovine Viral Diarrhea Virus (BVDV), leading to a reduced prevalence rate of 1.5% [35], this study reveals that BVDV seroprevalence remains high in Serbia, particularly contingent on farm size. For herds with up to 50 animals, the seroprevalence was determined to be 16%, surpassing the prevalence observed in a study focused solely on backyard farms in the Belgrade area, where it was 3.8%, albeit with within-herd rates of up to 80% [18]. However, variations in prevalence are evident concerning region and farm management, but within-herd prevalence usually approaches 100% [36]. Globally, the seropositivity rate stands at 42.77%, with dairy cattle demonstrating the highest prevalence at 48.68%. Notably, positive rates were more pronounced during summer (60.16%) and winter (63.44%), while cows exhibited a lower positivity rate compared to bulls, and calves showed a lower rate compared to adult cattle [35]. In comparison to antibodies, BVDV is considerably less detectable. In this study, only 8% of nasal swabs from such animals contained BVDV, which is lower than the global average [35].
BPIV3 and BRSV were concurrently detected on two large farms, despite BVDV and BoHV-1, which are typically absent for BPIV3 and BRSV to become predominant viral pathogens according to previous research [37]. Confirmation of the concurrent circulation of BVDV, BHV-1, and BPIV3 was obtained from a single large farm. The immunosuppression induced by BVDV infection facilitates the ease of other infections, resulting in a synergistic effect on numerous viral and bacterial pathogens responsible for respiratory illnesses.
The study underscores the endemic nature and complex dynamics of viral pathogens associated with BRDC in Serbian cattle, influenced by factors such as farm size. Further research and targeted control measures are needed to mitigate the impact of these diseases on cattle health and productivity in Serbia.

5. Conclusions

The study emphasizes that viral pathogens linked to BRDC in Serbian cattle are not only prevalent but also exhibit intricate interactions, indicating an endemic nature. These pathogens, including BVDV, BHV-1, BRSV, and BPIV3, play a significant role in the occurrence and severity of BRDC. Importantly, the dynamics of these pathogens are influenced by various factors, with farm size being a notable factor. This underscores the importance of considering farm size as a factor in understanding and addressing BRDC in Serbian cattle herds. Further research is warranted to delve deeper into these complex dynamics, including investigating how farm management practices and environmental factors may also contribute to disease prevalence and transmission. Moreover, the study highlights the need for targeted control measures to effectively mitigate the impact of these diseases on cattle health and productivity in Serbia. This includes implementing vaccination programs, improving biosecurity measures, and enhancing surveillance efforts to monitor disease prevalence and detect outbreaks early. By better understanding the endemic nature and dynamics of these viral pathogens and implementing appropriate control strategies, it is possible to reduce the burden of BRDC on Serbian cattle herds, ultimately improving animal welfare and economic outcomes for cattle producers.

Author Contributions

Conceptualization, V.M. and F.S.; methodology, D.G. and S.R.; formal analysis, S.Š. and M.Đ.; investigation, M.N and B.M.; resources, V.M.; writing—original draft preparation, M.D.; writing—review and editing, D.G.; supervision, V.M. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by the Serbian Ministry of Science, Technological Development and Innovation (Contract No 451-03-66/2024-03/ 200030).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data underlying this study are available upon request. Interested parties may contact the corresponding author for access to the dataset, subject to any confidentiality or data sharing agreements.

Conflicts of Interest

The authors declare no conflicts of interests.

References

  1. Bell, R.L.; Turkington, H.L.; Cosby, S.L. The Bacterial and Viral Agents of BRDC: Immune Evasion and Vaccine Developments. Vaccines (Basel) 2021, 9. [CrossRef]
  2. Johnson, K.K.; Pendell, D.L. Market Impacts of Reducing the Prevalence of Bovine Respiratory Disease in United States Beef Cattle Feedlots. Front Vet Sci 2017, 4. [CrossRef]
  3. Loneragan, G.H.; Dargatz, D.A.; Morley, P.S.; Smith, M.A. Trends in Mortality Ratios among Cattle in US Feedlots. J Am Vet Med Assoc 2001, 219 8, 1122–1127.
  4. Lemon, J.L.; McMenamy, M.J. A Review of UK-Registered and Candidate Vaccines for Bovine Respiratory Disease. Vaccines (Basel) 2021, 9.
  5. Werid, G.M.; Miller, D.; Hemmatzadeh, F.; Messele, Y.E.; Petrovski, K. An Overview of the Detection of Bovine Respiratory Disease Complex Pathogens Using Immunohistochemistry: Emerging Trends and Opportunities. Journal of Veterinary Diagnostic Investigation 2024, 36, 12–23.
  6. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine Influenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human Influenza C Viruses. PLoS Pathog 2013, 9. [CrossRef]
  7. Nissly, R.H.; Zaman, N.; Ibrahim, P.A.S.; McDaniel, K.; Lim, L.; Kiser, J.N.; Bird, I.; Chothe, S.K.; Bhushan, G.L.; Vandegrift, K.; et al. Influenza C and D Viral Load in Cattle Correlates with Bovine Respiratory Disease (BRD): Emerging Role of Orthomyxoviruses in the Pathogenesis of BRD. Virology 2020, 551, 10–15. [CrossRef]
  8. Kurcubic, V.; Djokovic, R.; Ilic, Z.; Vaskovic, N.; Petrovic, M. Bovine Respiratory Disease Complex (BRDC): A Review of Lung Lesions and Reducing of Quality of Carcasses. Biotechnology in Animal Husbandry 2019, 35, 209–217. [CrossRef]
  9. Kamel, M.S.; Davidson, J.L.; Verma, M.S. Strategies for Bovine Respiratory Disease (BRD) Diagnosis and Prognosis: A Comprehensive Overview. Animals 2024, 14.
  10. Cavirani, S. Immunization of Calves and Herd Immunity to Bovine Respiratory Disease Complex (BRDC). Large Animal Review 2019, 25, 17–24.
  11. Hoffmann, B.; Depner, K.; Schirrmeier, H.; Beer, M. A Universal Heterologous Internal Control System for Duplex Real-Time RT-PCR Assays Used in a Detection System for Pestiviruses. J Virol Methods 2006, 136, 200–209. [CrossRef]
  12. Kishimoto, M.; Tsuchiaka, S.; Rahpaya, S.S.; Hasebe, A.; Otsu, K.; Sugimura, S.; Kobayashi, S.; Komatsu, N.; Nagai, M.; Omatsu, T.; et al. Development of a One-Run Real-Time PCR Detection System for Pathogens Associated with Bovine Respiratory Disease Complex. Journal of Veterinary Medical Science 2017, 79, 517–523. [CrossRef]
  13. Abril, C.; Engels, M.; Liman, A.; Hilbe, M.; Albini, S.; Franchini, M.; Suter, M.; Ackermann, M. Both Viral and Host Factors Contribute to Neurovirulence of Bovine Herpesviruses 1 and 5 in Interferon Receptor-Deficient Mice. J Virol 2004, 78, 3644–3653. [CrossRef]
  14. Henritzi, D.; Hoffmann, B.; Wacheck, S.; Pesch, S.; Herrler, G.; Beer, M.; Harder, T.C. A Newly Developed Tetraplex Real-Time RT-PCR for Simultaneous Screening of Influenza Virus Types A, B, C and D. Influenza Other Respir Viruses 2019, 13, 71–82. [CrossRef]
  15. Thonur, L.; Maley, M.; Gilray, J.; Crook, T.; Laming, E.; Turnbull, D.; Nath, M.; Willoughby, K. One-Step Multiplex Real Time RT-PCR for the Detection of Bovine Respiratory Syncytial Virus, Bovine Herpesvirus 1 and Bovine Parainfluenza Virus 3. BMC Vet Res 2012, 8. [CrossRef]
  16. Kwasnik, M.; Rola, J.; Rozek, W. Influenza D in Domestic and Wild Animals. Viruses 2023, 15.
  17. Gaudino, M.; Moreno, A.; Snoeck, C.J.; Zohari, S.; Saegerman, C.; O’donovan, T.; Ryan, E.; Zanni, I.; Foni, E.; Sausy, A.; et al. Title: Emerging Influenza D Virus Infection in European Livestock as Determined in Serology Studies: Are We Underestimating Its Spread over the Continent?;
  18. Sapundžić, Z.Z.; Ninković, M.; Glišić, D.; Milovanović, B.; Žutić, J.; Kureljušić, B.; Milićević, V. Seroprevalence of Bovine Viral Diarrhea on Smallholder Farms on the Territory of Belgrade City. Acta Veterinaria Belgrade 2021, 71, 318–325. [CrossRef]
  19. Hashemi, M.; Bakhshesh, M.; Khezri, M.; Gharagouzlouian, M.M.; Tavakoli, G. A Two-Year Serological Study of Bovine Viral Diarrhea Virus, Bovine Alphaherpesvirus 1 and Bovine Parainfluenza Virus Type 3 in Qazvin Dairy Cattle Farms, Northwestern of Iran. Vet Arh 2022, 92, 1–10. [CrossRef]
  20. Veljović, L.; Knežević, A.; Milić, N.; Krnjaić, D.; Miković, R.; Zorić, A.; Marković, M.; Milicević, V.; Stamenković, M.; Stanojević, M.; et al. Isolation and Molecular Detection of Bovine Parainfluenza Virus Type 3 in Cattle in Serbia. Acta Veterinaria Belgrade 2016, 66, 509–519. [CrossRef]
  21. Werid, G.M.; Van, T.D.; Miller, D.; Hemmatzadeh, F.; Fulton, R.W.; Kirkwood, R.; Petrovski, K. Bovine Parainfluenza-3 Virus Detection Methods and Prevalence in Cattle: A Systematic Review and Meta-Analysis. Animals 2024, 14.
  22. Makoschey, B.; Berge, A.C. Review on Bovine Respiratory Syncytial Virus and Bovine Parainfluenza – Usual Suspects in Bovine Respiratory Disease – a Narrative Review. BMC Vet Res 2021, 17.
  23. Gaudino, M.; Nagamine, B.; Ducatez, M.F.; Meyer, G. Understanding the Mechanisms of Viral and Bacterial Coinfections in Bovine Respiratory Disease: A Comprehensive Literature Review of Experimental Evidence. Vet Res 2022, 53, 70.
  24. Ohlson, A.; Alenius, S.; Tråvén, M.; Emanuelson, U. A Longitudinal Study of the Dynamics of Bovine Corona Virus and Respiratory Syncytial Virus Infections in Dairy Herds. Veterinary Journal 2013, 197, 395–400. [CrossRef]
  25. Bidokhti, M.R.M.; Tråvén, M.; Ohlson, A.; Zarnegar, B.; Baule, C.; Belák, S.; Alenius, S.; Liu, L. Phylogenetic Analysis of Bovine Respiratory Syncytial Viruses from Recent Outbreaks in Feedlot and Dairy Cattle Herds. Arch Virol 2012, 157, 601–607. [CrossRef]
  26. Hoppe, I.B.A.L.; de Medeiros, A.S.R.; Arns, C.W.; Samara, S.I. Bovine Respiratory Syncytial Virus Seroprevalence and Risk Factors in Non-Vaccinated Dairy Cattle Herds in Brazil. BMC Vet Res 2018, 14. [CrossRef]
  27. Lachowicz-Wolak, A.; Klimowicz-Bodys, M.D.; Płoneczka-Janeczko, K.; Bykowy, M.; Siedlecka, M.; Cinciała, J.; Rypuła, K. The Prevalence, Coexistence, and Correlations between Seven Pathogens Detected by a PCR Method from South-Western Poland Dairy Cattle Suffering from Bovine Respiratory Disease. Microorganisms 2022, 10. [CrossRef]
  28. Klem, T.B.; Sjurseth, S.K.; Sviland, S.; Gjerset, B.; Myrmel, M.; Stokstad, M. Bovine Respiratory Syncytial Virus in Experimentally Exposed and Rechallenged Calves; Viral Shedding Related to Clinical Signs and the Potential for Transmission. BMC Vet Res 2019, 15. [CrossRef]
  29. Brock, J.; Lange, M.; Guelbenzu-Gonzalo, M.; Meunier, N.; Vaz, A.M.; Tratalos, J.A.; Dittrich, P.; Gunn, M.; More, S.J.; Graham, D.; et al. Epidemiology of Age-Dependent Prevalence of Bovine Herpes Virus Type 1 (BoHV-1) in Dairy Herds with and without Vaccination. Vet Res 2020, 51. [CrossRef]
  30. Barrett, D.; Parr, M.; Fagan, J.; Johnson, A.; Tratalos, J.; Lively, F.; Diskin, M.; Kenny, D. Prevalence of Bovine Viral Diarrhoea Virus (BVDV), Bovine Herpes Virus 1 (BHV 1), Leptospirosis and Neosporosis, and Associated Risk Factors in 161 Irish Beef Herds. BMC Vet Res 2018, 14. [CrossRef]
  31. Raaperi, K.; Nurmoja, I.; Orro, T.; Viltrop, A. Seroepidemiology of Bovine Herpesvirus 1 (BHV1) Infection among Estonian Dairy Herds and Risk Factors for the Spread within Herds. Prev Vet Med 2010, 96, 74–81. [CrossRef]
  32. Woodbine, K.A.; Medley, G.F.; Moore, S.J.; Ramirez-Villaescusa, A.M.; Mason, S.; Green, L.E. A Four Year Longitudinal Sero-Epidemiological Study of Bovine Herpesvirus Type-1 (BHV-1) in Adult Cattle in 107 Unvaccinated Herds in South West England. BMC Vet Res 2009, 5. [CrossRef]
  33. Paller, T.; Hostnik, P.; Pogacnik, M.; Toplak, I. The Prevalence of Ten Pathogens Detected by a Real-Time PCR Method in Nasal Swab Samples Collected from Live Cattle with Respiratory Disease;
  34. Wernicki, A.; Urban-Chmiel, R.; Rola, J.; Socha, W.; Stęgierska, D.; Dec, M.; Puchalski, A. Prevalence of Bovine Herpes Virus Type 1 in Small Herds of Young Beef Cattle in South-Eastern Poland-a Preliminary Study. Bulletin of the Veterinary Institute in Pulawy 2015, 59, 467–471. [CrossRef]
  35. Mahmmod, Y.; F Neamat-Allah, A.N.; Verna, A.; Rahmanian, V.; Shi, K.; Du, R.; H-y, L.; L-m, L.; J-y, Y.; Q-x, M.; et al. Prevalence of Bovine Viral Diarrhea Virus in Cattle between 2010 and 2021: A Global Systematic Review and Meta-Analysis;
  36. Petrović, T.; Lazić, S.; Lupulović, D.; Bugarski, D.; Đuričin, B. Rezultati Ispitivanja Raširenosti BVDV Infekcije u Velikim i Malim Zapatima Goveda Na Području Južnobačkog i Sremskog Okruga; 2008; Vol. 1;.
  37. Mehinagic, K.; Pilo, P.; Vidondo, B.; Stokar-Regenscheit, N. Coinfection of Swiss Cattle with Bovine Parainfluenza Virus 3 and Mycoplasma Bovis at Acute and Chronic Stages of Bovine Respiratory Disease Complex. Journal of Veterinary Diagnostic Investigation 2019, 31, 674–680. [CrossRef]
Table 1. Seroprevalence of Viral Pathogens in Serbian Cattle Farms.
Table 1. Seroprevalence of Viral Pathogens in Serbian Cattle Farms.
Farm size Number of farms/number of tested animals BRSV BVDV BHV-1 BPIV3
Seropositive herds (number/%) Seropositive animals (number/%) Seropositive herds (number/%) Seropositive animals (number/%) Seropositive herds (number/%) Seropositive animals (number/%) Seropositive herds (number/%) Seropositive animals (number/%)
1-50 animals 50/400 40/80 331/82.75 8/16 197/49.25 10/20 325/81.25 50/100 379/94.75
51-200 animals 10/300 10/100 260/86.67 5/50 150/50 10/100 283/94.33 10/100 210/70
More than 200 animals 5/300 5/100 245/81.67 4/80 193/64.33 5/100 290/96.67 5/100 250/83.33
TOTAL 65/1000 55/84.61 836/83.6 17/26.15 540/54 25/38.46 898/89.8 65/100 839/83.9
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated